Luminist Labs
Diagnostic platform for early detection of liver disease
Acquired
Storm Stillman · 1 founder
2026Acquired
AcquiredTeam
2
current
Co-founders
1
current
Stage
Acquired
Profile coverage4 of 8 · missing Funding, Signals, Customers, Stack / tools · last run 8/11/2026
About
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.